Evidence map›Paper›PMID 39534786›Full record

ArticleAtherosclerosis plus2024

A collaborative effort across Africa to investigate risk factors and outcomes of premature acute coronary syndrome: Protocol for the EAS Lipid Registry of Africa (LIPRA).

Ashraf Reda, Alexander R M Lyons, Alberto Zambon, Ahmed Bendary, Mutaz Al-Khnifsawi, Habib Gamra, David Marais, Okechukwu S Ogah, Tigist Seleshi, Ahmed A A Suliman and 14 more

Abstract read
In one paragraph

Article in Atherosclerosis plus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ashraf RedaCardiology Department, College of Medicine, Menofia University, Shibin Al Kawm, Al Minufiyah, Egypt.
Alexander R M LyonsFreelance Consultancy on behalf of European Atherosclerosis Society, Gothenburg, Sweden.
Alberto ZambonDepartment of Medicine, University of Padua School of Medicine, Italy.
Ahmed BendaryCardiology Department, Benha Faculty of Medicine, Benha University, Egypt.
Mutaz Al-KhnifsawiUniversity of Warith Al-Anbiyaa, College of Medicine, Karbala, Iraq.
Habib GamraFaculty of Medicine and University of Monastir, Tunisia.
David MaraisDivision of Chemical Pathology, Department of Pathology, Health Science Faculty, University of Cape Town, Cape Town, Western Cape Province, South Africa.
Okechukwu S OgahCardiology Unit, Department of Medicine, University of Ibadan, University College Hospital, Ibadan, Oyo state, Nigeria.
Tigist SeleshiDepartment of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Ahmed A A SulimanDepartment of Medicine, Faculty of Medicine, University of Khartoum, Sudan.
Julius C MwitaDepartment of Internal Medicine, University of Botswana and Princess Marina Hospital, Gaborone, Botswana.
Albertino DamascenoFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Anastase DzudieService of Cardiovascular Medicine and Subspecialties, Douala General Hospital, Douala, Cameroon.
Atef ElbahryHeart Centre Port-Fouad, Port-Said, Egypt.
Elsayed FaragZagazig University, Egypt.
Chala FekaduDepartment of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Lilian MbauCentre for Cardiovascular Disease Prevention and Rehabilitation, Nairobi, Kenya.
Mohammed MujahedSudan Lipid Clinic, Khartoum, Sudan.
Rosemary P MinjaDepartment of Internal Medicine, Muhimbili National Hospital, Mloganzila, Tanzania.
Bernard SamiaMP Shah Hospital, Nairobi, Kenya.
Mahmoud SaniDepartment of Medicine, Bayero University Kano & Aminu Kano Teaching Hospital, Kano, Nigeria.
Lambert T AppiahSchool of Medical Sciences (KNUST-SMS), Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Alexandros TselepisUniversity of Ioannina, Ioannina, Greece.
EAS Lipid Registry of Africa Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data on acute coronary syndrome (ACS) is lacking in Africa where cases of premature ACS seem to be on the rise. Africa would benefit from an epidemiological assessment of premature ACS to determine its risk factors and management in this demographic to inform guidelines and practice. The European Atherosclerosis Society recognised this urgency and formed a growing network across 11 African countries to create the Lipid Registry of Africa (EAS-LIPRA). This article is based on the EAS-LIPRA protocol and presents the aims, concept and methodological considerations, and the operations and collaborative governance structure of this project. EAS-LIPRA aims to report risk factors and outcomes of premature ACS in Africa to further understand its prevalence and management via collating and pooling multinational prospective data on premature ACS across multiple sites in Africa into a standardised registry. Data will be stratified into subgroups based on country-level income as defined by the World Bank, and within country residence of urban versus rural areas. Valid statistical procedures will be employed to compare and observe trends in the pooled data based on demographics, clinical and laboratory variables, and disparities in its management. Being the first multinational lipid registry in Africa, it is envisaged that the network will expand to other African countries and sites yet to participate, facilitate other epidemiological studies in preventive cardiology, and set a precedent for other developing countries and regions.

Indexed as

Acute coronary syndromeCardiovascular disease riskCoronary artery diseaseEAS LIPRANSTEMIPremature acute coronary syndromeSTEMIUnstable angina

Identifiers

PMID39534786
PMCPMC11555408

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.